Disease-Specific IgG Fc Glycosylation Ratios as Personalized Biomarkers to Differentiate Non-Small Cell Lung Cancer from Benign Lung Diseases.
Dan ZhangXiaoou LiXiaofeng LiuYanmin WangMo ZhangQing WangTianjing ChenZhili LiPublished in: Proteomics. Clinical applications (2019)
These findings indicate that these DSIgG Fc glycoforms are potential personalized biomarkers to differentiate NSCLC from BLDs.